Gilbert H. Kliman - 28 May 2026 Form 4/A - Amendment Insider Report for GLAUKOS Corp (GKOS)

Reporting relationship: Director
Issuer ticker: GKOS
Reported as of: 28 May 2026
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 23 Jun 2026, 19:24:29 UTC
Original report date: 01 Jun 2026
Prior SEC filing: 18 May 2026
Source filing: View source filing
Reporting owner signature: Diana Scherer, Attorney-in-Fact

Key filing fact

Gilbert H. Kliman filed Form 4/A - Amendment for GLAUKOS Corp (GKOS) on 23 Jun 2026.

Key facts

This page summarizes Gilbert H. Kliman's Form 4/A - Amendment filing for GLAUKOS Corp (GKOS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 23 Jun 2026, 19:24.

Change

Previous filing in this sequence was filed on 18 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001293171 Primary reporting owner

Kliman Gilbert H

Relationship: Director
Address: C/O GLAUKOS CORPORATION, ONE GLAUKOS WAY, ALISO VIEJO
Signature: Diana Scherer, Attorney-in-Fact
Signature date: 23 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GKOS transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +2,987
Change %
Price: $0.000000^*
Shares after: 2,987
Date: 28 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,987
Exercise price: $106.52
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This Form 4A amends a Form 4 filed June 1, 2026 that incorrectly reported the exercise price of options granted to the Reporting Person on May 28, 2026 as $53.57. The correct exercise price for the options granted is $106.52, as shown above.

Footnote F2

Granted pursuant to the Issuer's Director Compensation Policy. Vests in full on the one-year anniversary of grant date.